Yihe Yan

Also affiliated with First Affiliated Hospital of GuangXi Medical University, Hohhot First Hospital, Shaoxing People's Hospital, Shaanxi University of Science and Technology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells”.

Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02586-9

N/A

0DataRank · unranked

102 citations

Leting Zheng, Qiang Du, Bing Yan, David A. Geller, Yihe Yan

MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1

Biochemical and Biophysical Research Communications(2020)10.1016/j.bbrc.2020.01.034

N/A

0DataRank · unranked

16 citations

Qiang Du, Xiao Cui, Peiqi Wan, Christof Kaltenmeier, Jing Luo +4 more

Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting β-catenin in mice

PLoS ONE(2020)10.1371/journal.pone.0239119

N/A

0DataRank · unranked

12 citations

Jing Luo, Christof Kaltenmeier, Qiang Du, Donna B. Stolz, Patricia Loughran +4 more

Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)

Cancer Letters(2021)10.1016/j.canlet.2021.03.002

N/A

0DataRank · unranked

96 citations

Leting Zheng, Qiang Du, Hamza O. Yazdani, Kun Dong, Yarong Guo +2 more

IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin

Translational Oncology(2021)10.1016/j.tranon.2021.101059

N/A

0DataRank · unranked

37 citations

Jun Xu, Qiang Du, Yihe Yan, David A. Geller, Yarong Guo

Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells

British Journal of Cancer(2021)10.1038/s41416-021-01337-6

N/A

0DataRank · unranked

36 citations

Leting Zheng, Qiang Du, Xiao Cui, Kun Dong, Yarong Guo +2 more

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)

Journal of Translational Medicine(2023)10.1186/s12967-023-04716-0

N/A

0DataRank · unranked

50 citations

Qiulin Wu, David A. Geller, Yihe Yan, Jingquan Huang

Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages

Neoplasia(2023)10.1016/j.neo.2023.100900

N/A

0DataRank · unranked

25 citations

Huiyong Zhao, Sheng Wei, Qiang Du, Kun Dong, Yihe Yan +2 more

The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC

Frontiers in Immunology(2025)10.3389/fimmu.2025.1569915

N/A

0DataRank · unranked

24 citations

Yan Yang, Shixun Lin, David A. Geller, Yihe Yan, Qiulin Wu